找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Nutrition and Biotechnology in Heart Disease and Cancer; John B. Longenecker,David Kritchevsky,Marc K. Drez Book 1995 The Editor(s) (if ap

[复制链接]
查看: 10430|回复: 58
发表于 2025-3-21 16:16:52 | 显示全部楼层 |阅读模式
书目名称Nutrition and Biotechnology in Heart Disease and Cancer
编辑John B. Longenecker,David Kritchevsky,Marc K. Drez
视频video
丛书名称Advances in Experimental Medicine and Biology
图书封面Titlebook: Nutrition and Biotechnology in Heart Disease and Cancer;  John B. Longenecker,David Kritchevsky,Marc K. Drez Book 1995 The Editor(s) (if ap
描述There is a unique nutritional commonality developing in research relating to coronary heart disease and cancer. The primary aim of this conference was to provide a forum for the leading researchers, clinicians, educators and administrators in these two fields to present a program on heart disease and cancer which included a) the major historical milestones, b) the present areas of greatest interest in research and therapy, c) the latest nutritional, molecular, and biotechnological advances, and d) a perspective on the most promising areas for future research and therapy. Scientists have long contended that research marches on the feet of methodology. Thus there are numerous examples of research fields opening secondary to methodological advances. Some examples are: 1) thin layer and gas-liquid chromatography which, along with high pressure liquid chromatography have broadened the line of advances in lipid research and 2) peR and the resultant impact on molecular biological approaches to several fields of science. The organizers of this conference thought the time was propitious for bringing together knowledge on newer aspects of molecular biological research with current advances i
出版日期Book 1995
关键词biotechnology; cancer; chromatography; lipide; prevention; research
版次1
doihttps://doi.org/10.1007/978-1-4615-1957-7
isbn_softcover978-1-4613-5804-6
isbn_ebook978-1-4615-1957-7Series ISSN 0065-2598 Series E-ISSN 2214-8019
issn_series 0065-2598
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Busines
The information of publication is updating

书目名称Nutrition and Biotechnology in Heart Disease and Cancer影响因子(影响力)




书目名称Nutrition and Biotechnology in Heart Disease and Cancer影响因子(影响力)学科排名




书目名称Nutrition and Biotechnology in Heart Disease and Cancer网络公开度




书目名称Nutrition and Biotechnology in Heart Disease and Cancer网络公开度学科排名




书目名称Nutrition and Biotechnology in Heart Disease and Cancer被引频次




书目名称Nutrition and Biotechnology in Heart Disease and Cancer被引频次学科排名




书目名称Nutrition and Biotechnology in Heart Disease and Cancer年度引用




书目名称Nutrition and Biotechnology in Heart Disease and Cancer年度引用学科排名




书目名称Nutrition and Biotechnology in Heart Disease and Cancer读者反馈




书目名称Nutrition and Biotechnology in Heart Disease and Cancer读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:57:03 | 显示全部楼层
Signal Transduction in Atherosclerosis: Second Messengers and Regulation of Cellular Cholesterol Traas a chronic inflammatory response to high concentrations of native or modified low density lipoprotein (LDL), which in turn elicits a series of cellular and biochemical events which result in alterations in endothelial cell phenotype, macrophage infiltration, smooth muscle cell migration, prolifera
发表于 2025-3-22 03:32:27 | 显示全部楼层
发表于 2025-3-22 05:32:35 | 显示全部楼层
Impact of Biotechnology in the Diagnostic and Therapeutic Management of Cardiovascular Disordersve to be useful in the management of antithrombotic disorders. Although the use of transgenic animals is still at experimental stages, the initial findings are promising and will provide important leads into the development of therapeutic proteins. Through biotechnology, recombinant inhibitors of fi
发表于 2025-3-22 11:36:14 | 显示全部楼层
发表于 2025-3-22 14:11:54 | 显示全部楼层
发表于 2025-3-22 20:08:55 | 显示全部楼层
发表于 2025-3-23 00:26:44 | 显示全部楼层
Gardner C. McMillane of many Ets target genes in transformation. A better understanding of the role of Ets factors and their target genes in cancer should provide the basis for more specific novel therapeutic approaches for the treatment of cancers.
发表于 2025-3-23 01:49:45 | 显示全部楼层
Herman A. Tyrolere of many Ets target genes in transformation. A better understanding of the role of Ets factors and their target genes in cancer should provide the basis for more specific novel therapeutic approaches for the treatment of cancers.
发表于 2025-3-23 06:35:47 | 显示全部楼层
Kenneth B. Pomerantz,Andrew C. Nicholson,David P. Hajjar seems to be the leading factor in controlling the regulation of the promoter. Therefore, by engineering these elements, different types of promoters such as inducible promoters, tissue-spatial specific promoters, and constitutive promoters can be developed and used to drive various pathogen resistance genes.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-17 22:48
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表